TransMedics Group, Inc.

NasdaqGM:TMDX

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🩺 Medical Instruments

Location

United States

Market Cap

USD 4.34 B

Share Price

USD 127.26

Avg Daily Volume

1,029,087

Change (1 day)

11.14%

Change (1 year)

-21.87%

Change (YTD)

104.11%

TransMedics Group, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2025: 15.86%

TransMedics Group, Inc. EBIT Margin is 15.86% for the Trailing 12 Months (TTM) ending June 30, 2025, a 528.28% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

TransMedics Group, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was 2.52%, a -130.95% change year over year.
TransMedics Group, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was -8.16%, a -90.45% change year over year.
TransMedics Group, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was -85.45%, a -1.96% change year over year.
TransMedics Group, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was -87.17%, a -31.07% change year over year.